Issues: Vax Specific

● Anthrax

● Hepatitis B

● Hib

● HPV

● Influenza

● Lyme Disease
● Meningococcal

● MMR    

● Polio

● Rotavirus

● Smallpox

● Tdap/Td

● Varicella

● Yellow Fever

 

Issues: Misc

● Exemptions

● Legislation 

● New Vax Status

● Thimerosal

● Independent Vax  Safety Board

 

Vaccine Info

● 2009 Schedule

● ACIP Recs

● Components
● IOM Reports

● Vax Injury Comp Program
● Manufacturer Links

● Package Inserts

● Reporting AEs

● Thimerosal Table

● VAERS

● VISs

 

Links
 

Search
 

About IVS

● Faculty Biographies

● Publications

● Donations

 

Email IVS

 

Disclaimers & Privacy
 
 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu
 
 		  

INFLUENZA VACCINE

  • Currently there is no human influenza vaccine against swine flu.  We anticipate manufacturers will be developing a vaccine.  More information about Swine Flu is available from CDC (Apr 09)

  • The US FDA approved FluMist, by MedImmune, for use in people 2-49 years of age.  This expansion now includes children 2-5 years of age.  FDA Press Release (9-19-07)
    Influenza Vaccines Approved for US
     2008-09
    Vaccine Manufacturer Ages
    Afluria CSL 18 yrs and older
    Fluarix GSK 18 yrs and older
    FluLaval GSK 18 yrs and older
    FluMist MedImmune 2-49 yrs
    Fluvirin Novartis 4 yrs and older
    Fluzone sanofi pastuer 6 mos and older

  • The US FDA approved Glaxo SmithKline's FluLaval influenza virus vaccine. FluLaval is for adults 18 years and older to protect against strains of influenza projected to impact the Northern Hemisphere in the 2006/07 flu season. FluLaval is manufactured by ID Biomedical Corp (a Canadian subsidiary of GlaxoSmithKline) and distributed by GSK. FDA Press Release (10-05-06)

  • The US FDA announces approval of Fluarix, an inactivated influenza vaccine for adults. Fluarix is manufactured in Germany by a subsidiary of GlaxoSmithKline.  FDA Press Release (08-31-05)

  • CDC's guidelines for controlling influenza transmission in long-term care facilities (11-15-07).  PDF (150k) | HTML version

  • A new Influenza vaccine will be available for the 2005/6 Flu Season:  The FDA has approved the license supplement of sanofi pasteur) to market a formula of their influenza vaccine produced without introducing preservatives at any step in the manufacturing process. Fluzone®, Influenza Virus Vaccine, No Preservative, Pediatric Dose is the only influenza vaccine approved for use in the U.S. in children as young as 6 months. The vaccine will be available in 0.25 mL pediatric dose and 0.50 mL for children 3 years and older. (03-09-05)

  • The Centers for Disease Control and Prevention has a web page devoted to the Seasonal Flu containing a wide variety of information and updates including the a US map showing flu influenza activity. 
 

This page was last updated on June 11, 2009

© 2009 Institute for Vaccine Safety